Eyenovia (EYEN) News Today $0.06 0.00 (-5.15%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Eyenovia announces advisory firms recommend vote ‘FOR’ reverse stock splitJanuary 16 at 5:01 PM | markets.businessinsider.comEyenovia secures $1 million from warrant repricing and exerciseJanuary 16 at 5:01 PM | msn.comEyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of StockholdersJanuary 15 at 7:00 AM | globenewswire.comEyenovia (NASDAQ:EYEN) Stock Quotes, Forecast and News SummaryJanuary 12, 2025 | benzinga.comEyenovia Hires Financial Adviser Amid Business ReviewJanuary 6, 2025 | marketwatch.comEyenovia Engages Chardan as Advisor for Review of Strategic AlternativesJanuary 6, 2025 | globenewswire.comEyenovia’s $1.9M Offering to Boost Optejet DevelopmentDecember 9, 2024 | markets.businessinsider.comEyenovia Prices $1.9 Mln Registered Direct OfferingDecember 9, 2024 | markets.businessinsider.comEyenovia announces pricing of $1.9M registered direct offeringDecember 6, 2024 | markets.businessinsider.comEyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct OfferingDecember 6, 2024 | globenewswire.comEyenovia defers loan payments, issues equity to lendersNovember 27, 2024 | uk.investing.comEyenovia Slumps On Pricing Of Registered Direct OfferingNovember 27, 2024 | nasdaq.comEyenovia’s Direct Offering to Support Strategic InitiativesNovember 26, 2024 | markets.businessinsider.comEyenovia to sell 12.1M shares at 10.76c in registered direct offeringNovember 26, 2024 | markets.businessinsider.comEyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct OfferingNovember 25, 2024 | finance.yahoo.comEyenovia taking additional actions to reduce personnel-related costs by over 70%November 23, 2024 | finance.yahoo.comEyenovia, Inc.: Eyenovia Provides Update on Restructuring EffortsNovember 22, 2024 | finanznachrichten.deEyenovia Provides Update on Restructuring EffortsNovember 22, 2024 | globenewswire.comLadenburg Thalmann Downgrades Eyenovia (EYEN)November 20, 2024 | msn.comEyenovia downgraded to Neutral from Buy at LadenburgNovember 20, 2024 | markets.businessinsider.comEyenovia downgraded to Neutral from Buy at H.C. WainwrightNovember 20, 2024 | markets.businessinsider.comEyenovia stock plummets following Phase III myopia trial failureNovember 19, 2024 | msn.comEyenovia downgraded to Hold from Buy at BrooklineNovember 15, 2024 | markets.businessinsider.comEyenovia downgraded to Market Perform from Outperform at William BlairNovember 15, 2024 | markets.businessinsider.comEyenovia to Cut 50% of Workforce After Phase 3 Study DisappointsNovember 15, 2024 | marketwatch.comEyenovia to End Eye Drug Study, Cut 50% of Its WorkforceNovember 15, 2024 | money.usnews.comEyenovia Mulls Options After Phase 3 Study FailureNovember 15, 2024 | marketwatch.comEyenovia plans to terminate Phase 3 CHAPERONE study after DRC reviewNovember 15, 2024 | markets.businessinsider.comEyenovia Shares Plumb New Depths After Study FailureNovember 15, 2024 | marketwatch.comEyenovia Third Quarter 2024 Earnings: Misses ExpectationsNovember 15, 2024 | finance.yahoo.comEyenovia to end eye drug study after missing late-stage goal, shares fallNovember 15, 2024 | msn.comEyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From PipelineNovember 15, 2024 | benzinga.comEyenovia to discontinue late-stage study for eye drugNovember 15, 2024 | reuters.comEyenovia Provides Update on Phase 3 CHAPERONE StudyNovember 15, 2024 | globenewswire.comEyenovia price target lowered to $4.50 from $7 at LadenburgNovember 13, 2024 | markets.businessinsider.comEyenovia’s Strategic Advances and Q3 FinancialsNovember 13, 2024 | markets.businessinsider.comEyenovia’s Promising Growth Prospects: Buy Rating Affirmed by AnalystNovember 13, 2024 | markets.businessinsider.comEyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesNovember 13, 2024 | finance.yahoo.comEyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 13, 2024 | markets.businessinsider.comEyenovia, Inc. (EYEN) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comEarnings Outlook For EyenoviaNovember 12, 2024 | benzinga.comEyenovia to Report Third Quarter 2024 Results on Tuesday, November 12thNovember 7, 2024 | globenewswire.comEyenovia announces publication of study on Optejet, presentationOctober 24, 2024 | markets.businessinsider.comEyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®October 23, 2024 | finance.yahoo.comEyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 ExpoOctober 16, 2024 | finance.yahoo.comEyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 ExpoOctober 16, 2024 | globenewswire.comEyenovia Inc (EYEN) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesOctober 9, 2024 | finance.yahoo.comEyenovia Inc.October 4, 2024 | wsj.comEyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet DeviceOctober 1, 2024 | markets.businessinsider.comEyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet DeviceOctober 1, 2024 | globenewswire.com Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address EYEN Media Mentions By Week EYEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EYEN News Sentiment▼0.310.46▲Average Medical News Sentiment EYEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EYEN Articles This Week▼52▲EYEN Articles Average Week Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VTVT News Today ESLA News Today ELEV News Today RAPT News Today CLNN News Today LTRN News Today CASI News Today TPST News Today PASG News Today ATNM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EYEN) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eyenovia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eyenovia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EYEN Stock Alerts